Galveston, TX, United States of America

John S Bergmann


Average Co-Inventor Count = 3.4

ph-index = 2

Forward Citations = 23(Granted Patents)


Company Filing History:


Years Active: 2004-2017

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations of John S Bergmann

Introduction

John S Bergmann is a notable inventor based in Galveston, Texas. He holds a total of four patents that reflect his contributions to the fields of biomedical engineering and therapeutic development. His work has significantly advanced the understanding and application of various medical technologies.

Latest Patents

One of his latest patents is titled "Apparatuses and methods for forming wounds in cell layers." This invention includes an apparatus designed to create wounds in cell layers using a sliding member that drags a scratching element through the cell layer. This innovative approach has potential applications in cellular research and therapy. Another significant patent is "Antibodies to complementary peptides of thrombin or portions thereof." This patent discloses antibodies that bind to complementary peptides of thrombin, which can act as agonists or antagonists in thrombin receptor-mediated events. The methods outlined in this patent provide new avenues for treating conditions that require modulation of thrombin activity.

Career Highlights

Throughout his career, John S Bergmann has worked with esteemed organizations such as the University of Texas System and Orthologic Corporation. His experience in these institutions has allowed him to collaborate on various projects that bridge the gap between research and practical applications in medicine.

Collaborations

John has collaborated with notable colleagues, including Darrell H Carney and Roger S Crowther. These partnerships have contributed to the development of innovative solutions in the biomedical field.

Conclusion

John S Bergmann's contributions to innovation in medical technology are evident through his patents and collaborations. His work continues to influence the landscape of biomedical research and therapeutic development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…